Duane Nash
Président chez IMMUNIC, INC.
Fortune : 27 320 $ au 31/05/2024
Profil
Duane D.
Nash is currently the Executive Chairman at Immunic, Inc. and a Member-Supervisory Board at Immunic AG.
Previously, he served as the President, Chief Executive Officer & Director at Vital Therapies, Inc. in 2019.
From 2012 to 2017, he was a Director at Aerpio Therapeutics, Inc. He also served as an Independent Director at Akebia Therapeutics, Inc. from 2013 to 2018.
Prior to that, he worked as an Attorney at Davis Polk & Wardwell LLP from 2002 to 2008.
He was a Research Analyst at Pacific Growth Equities, Inc. and a Vice President at Wedbush Securities, Inc. He also held the position of Senior Vice President-Equity Research at Wedbush Pacgrow Healthcare from 2009 to 2012.
Dr. Nash holds an MBA from the University of Oxford, a graduate degree from the University of California, Berkeley, an undergraduate degree from Williams College, and a doctorate from Dartmouth Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNIC, INC.
0,02% | 31/03/2024 | 22 032 ( 0,02% ) | 27 320 $ | 31/05/2024 |
Postes actifs de Duane Nash
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | Président | 01/01/2019 |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Directeur/Membre du Conseil | - |
Anciens postes connus de Duane Nash
| Sociétés | Poste | Fin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/12/2018 |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Directeur/Membre du Conseil | 02/01/2017 |
Wedbush Pacgrow Healthcare
 Wedbush Pacgrow Healthcare Investment Banks/BrokersFinance Wedbush Pacgrow Healthcare is a private company that deals with exchange securities. The company is based in San Francisco, CA. | Corporate Officer/Principal | 01/03/2012 |
Pacific Growth Equities, Inc.
 Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Pacific Growth Equities, Inc. is a research-driven investment bank located headquartered in San Francisco with an additional office in Boston. The firm specializes in technology-based emerging growth companies. They offer investment banking and brokerage services including public equity offerings, private equity offerings and mergers and acquisitions. Pacific Growth focuses on the life sciences, technology, healthcare and consumer growth companies. | Analyst-Equity | 28/02/2009 |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/02/2008 |
Formation de Duane Nash
| University of Oxford | Masters Business Admin |
| University of California, Berkeley | Graduate Degree |
| Williams College | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Finance |
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Health Technology |
Davis Polk & Wardwell LLP
Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Commercial Services |
Pacific Growth Equities, Inc.
Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Pacific Growth Equities, Inc. is a research-driven investment bank located headquartered in San Francisco with an additional office in Boston. The firm specializes in technology-based emerging growth companies. They offer investment banking and brokerage services including public equity offerings, private equity offerings and mergers and acquisitions. Pacific Growth focuses on the life sciences, technology, healthcare and consumer growth companies. | Finance |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Wedbush Pacgrow Healthcare
Wedbush Pacgrow Healthcare Investment Banks/BrokersFinance Wedbush Pacgrow Healthcare is a private company that deals with exchange securities. The company is based in San Francisco, CA. | Finance |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
